Drug Profile

Fexofenadine/phenylephrine

Alternative Names: FEX60/PE10; Phenylephrine/fexofenadine

Latest Information Update: 05 Sep 2017

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Sanofi
Class Acetic acids; Antiallergics; Benzhydryl compounds; Decongestants; Ethanolamines; Nonsedating antihistamines; Piperidines; Small molecules
Mechanism of Action Alpha 1 adrenergic receptor agonists; Histamine H1 receptor antagonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

05 Sep 2017 No recent reports on development identified - Phase-III for Allergic rhinitis in Japan (PO)
01 Mar 2015 Phase-III clinical trials in Allergic rhinitis in Japan (PO) (NCT02401191)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com